A Trial With EMP16 in Preparation for Late Phase Studies

Clinical trial NCT06993428 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06993428
Sponsor: Empros Pharma AB
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Overweight or Obese Obesity and Overweight

Start date: 2025-05-20
Primary completion: 2025-07-29
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.